Arformoterol tartrate
| CAS No. | 200815-49-2 | Cat. No. | BCP04264 |
| Name | Arformoterol tartrate | ||
| Synonyms | (R,R)-ForMoterol-L-(+)-Tartrate; BD 40A; eformoterol; | ||
| Formula | C19H24N2O4.C4H6O6 | M. Wt | 494.494 |
| Description | Arformoterol tartrate is a long acting beta-adrenoceptor agonist drug indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion, under the trade name Brovana, as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization. It is the active (R,R)-enantiomer of formoterol and was approved by the United States Food and Drug Administration (FDA) on October 6, 2006 for the treatment of COPD. | ||
| Related Products | 67346-49-0（Arformoterol） | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | Adrenergic Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.